References
- S. G. Lee, J. J. Kim, D. H. Kweon, Y. J. Kang, S. D. Cho, S. K. Kim and Y. J. Yoon, Recent progress in pyridazin-3(2H)-ones chemistry, Curr. Med. Chem. 8 (2004) 1463-1480; DOI: 10.2174/1385272043369818.
- K. Abouzid, M. A. Hakeem, O. Khalil and Y. Maklad, Pyridazinone derivatives: design, synthesis, and in vitro vasorelaxant activity, Bioorg. Med. Chem. 16 (2008) 382-389; DOI: 10.1016/j.bmc.2007.09.03.
- K. A. M. Abou-Zeid, K. M. Youssef, M. A. Shaaban, F. A. El-Telbany and S. H. Al-Zanfaly, Synthesis of 6-(4-(substituted-amino)phenyl)-4,5-dihydropyridazin-3(2H)-ones as potential positive inotropic agents, Egypt. J. Pharm. Sci. 38 (1998) 319-331.
- T. Wang, Y. Dong, L. C. Wang and Z. Chen, Synthesis and bioactivity of 6-phenyl-4,5-dihydro-3(2H)-pyridazinone derivatives, Arzneimittelforschung 57 (2007) 641-647; DOI: 10.1002/chin. 200808160.
- C. V. Curran and A. Ross, 6-Phenyl-4,5-dihydro-3(2H)-pyridazinones. A series of hypotensive agents, J. Med. Chem. 17 (1974) 273-281; DOI: 10.1021/jm 00249a004.
- S. Archan and W. Toller, Levosimendan: current status and future prospects, Curr. Opin. Anaesthesiol. 21 (2008) 78-84; DOI: 10.1097/ACO.0b013e3282 f357a5.
- R. E. Weishaar, D. C. Kobylarz-Singer, R. P. Steffen and H. R. Kaplan, Subclasses of cyclic AMP-specific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility, Circ. Res. 61 (1987) 539-547.
- F. F. Owings, M. Fox, C. J. Kowalski and N. H. Baine, An enantioselective synthesis of SK&F 93505, a key intermediate for preparing cardiotonic agents, J. Org. Chem. 56 (1991) 1963-1966.
- B. S. Furniss, A. J. Hannaford, P. W. G. Smith and A. R. Tatchell, Aromatic Compounds, in Vogel's Text Book of Practical Organic Chemistry, 5th ed. (Ed. A. I. Vogel), Longman Group Ltd, Harlow 1989, pp. 824-1195.
- L. G. Sevillano, C. P. Melero, E. Caballero, F. Tomé, L. Lelièvre, K. Geering, G. Crambert, R. Carrón, M. Medarde and A. San Feliciano, Inotropic activity of hydroindenic amidinohydrazones, J. Med. Chem. 45 (2002) 127-136; DOI: 10.1021/jm0109309.
- M. Guerrero, P. Puebla, R. Carrón, M. L. Martín and L. San Román, Vasorelaxant effect of new neo-clerodane diterpenoids isolated from Croton schiedeanus, J. Ethnopharmacol. 94 (2004) 185-198; DOI: 10.1016/j.jep. 2004.05.018.
- T. Seki, A. Kanada, T. Nakao, M. Shiraiwa, H. Asano, K. Miyazawa, T. Ishimori, N. Minami, K. Shibata and K. Yasuda, Studies on agents with vasodilator and β-blocking activities. V.1) Synthesis and pharmacological activity of the optical isomers of TZC-5665, Chem. Pharm. Bull. 46 (1998) 84-96.
- M. Endoh, Basic and clinical characteristics of PDE 3 inhibitors as cardiotonic agents, Cardiovasc. Drugs Ther. 21 (2007) 135-139; DOI: 10.1007/s0557-007-6029-z.